The p107 activators are a group of chemical compounds that have the ability to stimulate the activity of the p107 protein, a member of the Retinoblastoma (Rb) family of pocket proteins. This protein family plays a pivotal role in the regulation of the cell cycle, particularly at the G1 phase checkpoint. The family includes three members: Rb (also known as p105 or Rb1), p107, and p130. Each of these proteins possesses a pocket domain, which serves as the binding site for a variety of cellular proteins, including the E2F family of transcription factors. The binding between the pocket proteins and E2Fs is essential for the suppression of E2F target genes that promote cell cycle progression. Among the Rb family, p107 has its unique biological roles, interactions, and regulatory mechanisms. Hence, the importance of modulating its activity through specific activators is emphasized.
In the realm of cellular biology, the precise regulation of the cell cycle is paramount for maintaining genomic stability and proper tissue development. p107, like its counterparts, functions as a negative regulator, ensuring that cells do not progress through the cell cycle in an uncontrolled manner. The interaction of p107 with E2F transcription factors prevents the premature expression of genes required for S-phase entry. p107 activators, by enhancing the activity of p107, bolster this regulatory function. The chemical structure, mechanism of action, and specificity of these activators can vary, but their central role remains the modulation of p107 activity. By understanding and studying these activators, researchers can gain deeper insights into cell cycle regulation and the intricate web of interactions that maintain cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
A well-known therapeutic compound that stabilizes microtubules and leads to cell cycle arrest. By preventing cell progression, it might indirectly influence p107 levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Another therapeutic agent that inhibits DNA synthesis and can cause cell cycle arrest, potentially influencing p107 dynamics. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
A cyclin-dependent kinase (CDK) inhibitor that can arrest the cell cycle by preventing CDK activity, potentially leading to an increase in p107. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
An inhibitor of CDK4/6, it can arrest cells in the G1 phase of the cell cycle. By blocking this phase, there could be an indirect influence on p107 levels. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
An MDM2 antagonist that stabilizes p53, a tumor suppressor. Since p53 has a broad range of effects, including on cell cycle regulation, it might indirectly influence p107. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Used in differentiation therapy, especially for acute promyelocytic leukemia. By driving cells to differentiate, it might alter the expression of cell cycle regulators, including p107. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can impact cell growth and proliferation. Its effects on the cell cycle and metabolism might indirectly influence p107. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
It's used to inhibit ribonucleotide reductase, leading to decreased DNA synthesis and S-phase cell cycle arrest. This can indirectly affect the levels or activity of p107. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $270.00 | 5 | |
Causes DNA breaks, leading to cell cycle arrest to facilitate DNA repair. This arrest can lead to the modulation of p107. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
A nucleoside analog that, upon incorporation, leads to chain termination during DNA replication. This can cause cell cycle arrest and may influence p107 dynamics. | ||||||